clinical setting News
-
Bio-Me at 4th National Microbiota Conference
During the 4th Norwegian National Microbiota Conference to be held in Oslo, Norway on 9th November, Dr. Morten Isaksen, CEO of Bio-Me has been invited to present Bio-Me and its contribution to use of information from the gut microbiome in clinical settings. The Conference gathers different groups that work within the field of microbiome/microbiota related aspects in Norway. This field is ...
By Bio-Me
-
Superiority vs gold standard demonstrated by in-vitro model
Biofilm creation - among others - is one of the most important factors linked to infections and almost the only one that can be measured through simulation. T-Control demonstrated superiority vs gold standard, i.e. significant differences were observed between the biofilm quantity generated on the product´s surface. This result reinforces the hypothesis that T-Control, with it´s ...
-
Microbial Migration in a Clinical Setting
If someone is admitted to hospital with an infectious disease there is always a risk that disease can spread. MRSA and viruses like it can, if left unchecked, infect entire hospital wards at an alarming rate leaving those recovering from other conditions or operations weak and vulnerable. Because hospitals can’t ever be closed environments, controlling the flow of potentially harmful ...
-
Pacific Edge Named In Deloitte Fast 50 Awards
Pacific Edge has once again been named in the Deloitte Fast 50 Awards, as it continues to execute on its commercial strategy and drive revenue growth. Pacific Edge was named 48th in the Fast 50 Index and the fastest growing export business for Dunedin and Lower South Island. The company, which has recently completed a highly successful and well supported capital raise, is now well positioned to ...
-
Chief Medical Officer and Co-founder Dr. Sam Browd featured in Orthoworld
Proprio Chief Medical Officer & Co-founder Dr. Sam Browd was recently featured in Orthoworld’s “Orthopedics Collecting and Parsing Data in New Ways Via AI” article. Why is AI needed in the orthopedic O.R.? Dr. Browd: The application of artificial intelligence in a clinical setting creates an increased capability to amalgamate highly complex, multidimensional ...
-
How to validate Laboratory Developed Test for COVID-19 detection in a clinical setting
At the upcoming webinar, Lumex Instruments’ client, 1Care Diagnostics, will share their insights and experience about Laboratory Developed Test (LDT) validation for CLIA-certified lab setting. While working on the LDT, 1Care Diagnostics used microchip-based real-time PCR technology for COVID-19 detection in saliva samples developed by Lumex Instruments. The system is based on PCR analyzer ...
-
Elekta Studio Launch
We are celebrating the launch of Elekta Studio this week! “On behalf of all at medPhoton, we are delighted about this cooperation with Elekta.” says Heinz Deutschmann, CEO. “A large number of our employees have a longstanding background in Radiation Oncology, where for many years we have developed technologies for adaptive image guided solutions for treatments with linear ...
-
Clinical investigations
We performed 2 clinical trials in leading neurorehabilitation hospitals in Germany and Spain proving safety, feasibility and usability of the exoskeleton in a clinical setting, and showing significant improvements in clinical outcomes and benefits in rehabilitation. A Multicentric Clinical investigation in Institut Guttmann (Spain) and Heidelberg University Hospital (Germany), leading European ...
-
Isabel releases new super-fast, multi-language version of its AI Symptom Checker Virtual Self-Triage Platform
Isabel Healthcare announced the release of the latest version of its AI Symptom Checker / Virtual Self-Triage platform. With the new release API response times have been cut by a third and a new multi-language capability added. This means that health institutions and developers around the world can use Isabel to help patients find care in the most appropriate clinical setting in less than a ...
-
EUON Publishes Nanopinion on Nanosilver in Healthcare
On August 31, 2020, the European Union (EU) Observatory for Nanomaterials (EUON) published a Nanopinion entitled “Nanosilver in healthcare — does the silver bullet exist?” by Dr. Dorota Napierska, Chemicals Policy and Projects Officer, Health Care Without Harm Europe (HCWH Europe). Napierska examines how beneficial the properties of nanosilver are in clinical settings and the ...
-
Repositioning From IV to Vial-Based SC for Large-Volume Biologics
Our expert discusses the growing trend of moving away from intravenous drugs administered in clinical and hospital settings to at-home, self-administered vial-based subcutaneous delivery for cost savings, better lifecycle management and improved care. Learn more about our technology by reading the latest article in On Drug ...
By Sonceboz SA
-
Xeltis CTO at FDA-led Pediatric Device Innovators Forum
Xeltis bio-restorative pulmonary heart valves and their clinical outcomes will feature at the upcoming Pediatric Device Innovators Forum organized by the U.S. Food and Drug Administration (FDA) in conjunction with five U.S. pediatric device consortia on 11 March. “I am looking forward to discussing the potential and the challenges of applying biomaterials to pediatric heart valve ...
By XELTIS BV
-
Neil Hayes, GeneCentric co-founder, highlighted for his work and upcoming AACR presentation by UTHSC where he is the Director of the Center for Cancer Research.
For two decades, scientists have been able to identify the molecular signature of specific cancers by isolating the RNA, responsible for dictating which proteins are produced and, by extension, how the cells behave in the body. Now, Neil Hayes, MD, MS, MPH, director of the Center for Cancer Research at the University of Tennessee Health Science Center, and a colleague at Washington University in ...
-
Interpreta Earns NCQA Measure Certification™ For Hedis and IHA AMP Measure Year 2020
Interpreta, Inc., the real-time healthcare quality analytics company, announced today it was certified for the seventh consecutive year by the National Committee for Quality Assurance (NCQA). Interpreta was certified for full Healthcare Effectiveness Data and Information Set (HEDIS®) in Measure Year 2020 (MY2020, and by NCQA for Integrated Healthcare Association’s (IHA) Align. Measure. ...
By Interpreta
-
Alertgy Awarded Patent US20200217809A1 Apparatus For In Vivo Dielectric Spectroscopy
Alertgy has been granted a patent for their innovative and groundbreaking radio frequency sensor technology. The awarded patent, Apparatus for in vivo dielectric spectroscopy (US20200217809A1), focuses on sensor technology that is 100% non-invasive and continuously monitors blood glucose in a way that does not involve blood oxidase, but rather dielectric spectroscopy and radio frequency. As a ...
By Alertgy
-
Nanox to Host Virtual Tour of Nanox.ARC in a Clinical Setting at the Radiology Society of America Annual Meeting and Announces Investor Webinar
NEVE ILAN, Israel--(BUSINESS WIRE)--Nov. 23, 2021-- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, will host a virtual tour of the Nanox.ARC at the RSNA Annual Meeting on December 1, 2021 at 11:30 am EST (10:30 am CST) as previously announced. The Company will follow the RSNA Virtual Tour by hosting an ...
-
Preclinical results of AdjuCor’s technology to be presented at the upcoming 101st annual meeting of the American Association for Thoracic Surgery (AATS)
In another great achievement for AdjuCor’s ground-breaking new technology within a short period of time, its submitted abstract has been accepted for presentation at the prestigious 101st American Association for Thoracic Surgery (#AATS2021). Prof. Stephan Schueler will be presenting specifics relating to the augmentation technology. Professor Stephan Schueler, Head of Mechanical ...
By AdjuCor GmbH
-
INRA congratulates partner MaaT Pharma on its award at the Worldwide Innovation Challenge
Work on intestinal microbiota carried out at INRA for more than 30 years has, with the recent development of metagenomics, led to new breakthroughs that have transformed our understanding of the ecosystem of the human digestive tract. Microbiota – the set of bacteria living in our digestive tract – is now considered an organ in itself. Acting on the microbiota for health reasons ...
-
Alveo Technologies Awarded Grant for its be.well™ COVID-19 Test
Alveo Technologies, today announced it has been awarded a grant to improve upon the performance and usability of its testing platform, and if successful, to advance the development and scale manufacturing of the company’s be.well™ COVID-19 test from the Bill & Melinda Gates Foundation. As the first of its kind platform, be.well™ is as accurate as a PCR test with all the ...
-
World premiere in plastic surgery at Maastricht UMC+
Microsure and Olympus teamed up in the world’s first case in plastic surgery in which robotic microsurgery was combined with their newest digital exoscope. Microsure’s MUSA and the Olympus OrbEye 3D 4K camera were used during a clinical case. With this set-up the surgeon is able to do so-called “heads up microsurgery”, which means the surgeon does not have to look through ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you